8-KEarnings & ResultsExhibits & Filings

AbbVie Inc. 8-K Report, Financial Results (May 1, 2020)

Filed May 1, 2020For Securities:ABBV

Summary

AbbVie Inc. (ABBV) filed an 8-K on May 1, 2020, to report its financial results for the first quarter ended March 31, 2020. The key information is contained within the press release furnished as Exhibit 99.1, which details the company's operational and financial performance during the period. Investors should review this press release for specific figures related to revenue, earnings, and any forward-looking guidance provided by the company. While the 8-K itself is a brief filing, it serves as the official notification and incorporation of the more detailed financial results announced publicly by AbbVie. The event date of April 30, 2020, indicates when the results were likely finalized or prepared for announcement, with the filing occurring on May 1, 2020. For a comprehensive understanding of AbbVie's Q1 2020 performance and outlook, direct reference to the furnished press release is essential.

Key Highlights

  • 1AbbVie Inc. reported its financial results for the first quarter ended March 31, 2020, via an 8-K filing on May 1, 2020.
  • 2The filing incorporates a press release (Exhibit 99.1) containing the detailed Q1 2020 financial results.
  • 3Investors can find information on operations and financial condition within the furnished press release.
  • 4The event date for the results announcement was April 30, 2020.
  • 5The 8-K serves as a formal record and public disclosure mechanism for the quarterly financial performance.
  • 6Review of Exhibit 99.1 is crucial for understanding specific revenue, earnings, and other financial metrics for Q1 2020.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report AbbVie Inc.'s financial results for the first quarter ended March 31, 2020, by incorporating the press release that announced these results.

The detailed financial results for Q1 2020 are contained within the press release dated May 1, 2020, which is furnished as Exhibit 99.1 to this 8-K filing and incorporated by reference.

The press release typically includes key financial metrics such as revenue, earnings per share (EPS), net income, and potentially guidance for future periods. For exact details, you must refer to Exhibit 99.1.

AbbVie's financial results for the first quarter ended March 31, 2020, were announced on or around May 1, 2020, with the underlying event date listed as April 30, 2020.